Note to the businessman

Note to the businessman

From shady scientists to charlatans

In Russia, due to the peculiarities of science financing and the state of the economy, there are several models of combining entrepreneurial and scientific activities.

24.11.2014

Note to the businessman

R&D in pharmaceuticals has gone up 2.5 times in 10 years

The cost of developing and launching a drug on the market has increased by 145% compared to 2003. The total cost of creating a new drug, including post-registration studies, reaches $2.9 billion.

21.11.2014

Note to the businessman

Choosing a venture

Biotechnologies, medicine, mobile applications, IT and new generations of robots and drones – what should far-sighted investors invest in?

12.11.2014

Note to the businessman

Peptides against alcohol addiction

Scientists from ADG-Pharm LLC, graduates of Lomonosov Moscow State University, presented a development that can bring the treatment of alcoholism to a qualitatively new level.

05.11.2014

Note to the businessman

Changes in the venture capital market

The volume of venture financing in Russian startups fell by 9% compared to the previous year, despite the fact that in the second quarter of 2014 the number of completed transactions increased by 32%.

23.09.2014

Note to the businessman

Trends in the development of medicine

HSE specialists consider the use of RNA aptamers for targeted drug delivery, implantable microchips for monitoring the treatment of chronic diseases and "pocket" biosensors for the diagnosis of acute respiratory viral infections to be the most promising trends in medicine.

12.09.2014

Note to the businessman

Manufacturers are betting on generics

Normally, there should be no more than 3-5 generics of one drug, and all of them are carefully tested. However, research takes a lot of time and money. And "under-researched" generics are not always happy with the results.

25.08.2014

Note to the businessman

LabCures – crowdfunding for biomedicine

A new commercial company LabCures, created by employees of the Institute for the Study of Aging of the Tank, plans to raise money for biomedical research using the Internet.

19.08.2014

Note to the businessman

The biggest risk for crowdfunding is "snake oil"

Sellers of "snake oil" (snake oil, a quack drug for all diseases) are one of the most dangerous problems of the nascent crowdfunding industry.

27.06.2014

Note to the businessman

Invest in bioprinting!

Investments in the biotechnology sector at the beginning of 2013 allowed market participants to double their investments. One of the most promising segments of the biotechnology market is 3D printing in general and bioprinting in particular.

24.06.2014

Note to the businessman

Who will win the race of high pharmaceutical technologies

The pharmaceutical company Novartis has thrown all its efforts into the development of drugs against cancer. And not just her.

23.06.2014

Note to the businessman

IT in medicine and pharmaceuticals – profitable investments

The Russian manufacturer of custom software Epam Systems bought the American manufacturer of software for pharmaceutical companies GGA Software Services, as well as the Institute of Theoretical Chemistry.

11.06.2014

Note to the businessman

Life Button

The idea of the startup "Button of Life" is to create an emergency call system for the elderly and disabled. The company plans to make a profit in 2 years.

10.06.2014

Note to the businessman

A miracle cure

Shares of the biotech company Pharmacyclics have risen forty times in six years. Will she continue to be successful?

06.05.2014

Note to the businessman

"Smart pills" at a low start

According to the results of a new study by Frost & Sullivan "Innovations in Smart Pills" (Innovations in Smart Pills), a boom in this market is expected in the next 5-6 years.

04.04.2014

Note to the businessman

Will crowdfunding help biomedical research?

Today, crowdfunding is a useful and relatively fast tool for financing small pilot experiments, the results of which can later be used when applying for larger grants.

10.02.2014

Note to the businessman

Money is the cause of all evil (G. Flaubert)

The richer we are, the less inclined we are to empathize with others and the stronger our confidence that we deserve everything we have. In addition, a high level of well-being determines the idea of avarice as a virtue, as well as the desire to represent the pursuit of personal gain as natural and moral.

16.01.2014

Note to the businessman

Nanomedicine is a profitable business

The level of annual growth of the nanomedicine market in monetary terms in the coming years will be on average 12.3% and by the end of 2019, it is expected to reach $ 177.6 billion.

13.01.2014

Note to the businessman

Save money for Rusnano shares

In May of this year, the President of the Russian Federation stated unequivocally: "There are no plans to privatize Rusnano in the foreseeable future." Reading the article published on the RusNanoNet portal, one cannot help but recall the once popular phrase: “Who is Mister Putin"?

20.12.2013

Note to the businessman

How successful are billionaires' investments in startups

Many entrepreneurs from the Forbes list have made a lot of money on venture projects. However, much more often venture investments of Forbes list members are loud PR and a graveyard of innovative projects.

20.11.2013